SCIO briefing on the progress of COVID-19 control and medical treatment

The State Council Information Office held a press conference on Friday afternoon in Wuhan, capital of central China's Hubei province, to brief the media on the progress of COVID-19 control and medical treatment. March 9, 2020

Channel NewsAsia:

The National Health Commission recently said that the outbreak in Hubei has been effectively contained. Given this situation, can we begin to lift prevention and control restrictions gradually? What level of epidemic prevention criteria should be achieved to lift restrictions? Thank you.

Ding Xiangyang:

Thank you for your questions. We have checked today's epidemic data. It should be said that the rapidly rising trend of the epidemic in Wuhan has been contained. However, it should also be noted that the number of daily confirmed and suspected cases in Wuhan and Hubei still accounts for a large proportion of the country's total. There are still around 20,000 patients in hospitals, and we still face great treatment pressure. Wuhan remains the key area of the country's epidemic prevention and control work.

As for the question of lifting restrictions gradually, I think we are all very concerned. With the improvement of the epidemic situation in Wuhan and Hubei, the relevant parties will report for approval and then make adjustments in a timely manner in accordance with the Law on the Prevention and Treatment of Infectious Diseases, as well as the Regulations on Preparedness for and Response to Emergent Public Health Hazards.

When I went out this morning, I saw that the cherry blossoms were blooming right in front of the door. This signals that winter has passed and spring is here. I think the day everyone is anticipating is not far away. Thank you.

Xi Yanchun:

Thank you all. That's the end of the briefing.

Translated and edited by Zhang Liying, Wang Qian, Li Xiao, Zhang Rui, Zhu Bochen, Qin Qi, Zhang Junmian, Zhang Jiaqi, Fan Junmei, Wang Yiming, Wu Jin, Wang Yanfang, Wang Zhiyong, He Shan, Yan Xiaoqing, Yang Xi, Yuan Fang, Gong Yingchun, Huang Shan, Duan Yaying, Guo Xiaohong, Li Huiru, Zhou Jing, Mi Xingang, Jay Birbeck, Laura Zheng, David Ball. In case of any dispute over a discrepancy, the Chinese version is deemed to prevail.

<  1  2  3  4  5  6  7  8  9  10  11  

Print E-mail Bookmark and Share